Parietaria judaica allergen extract SCIT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Parietaria judaica allergen extract SCIT, covering 2017-05-01 to 2017-05-01. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica [Phase 1]